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Secretory vesicles isolated from the neural and intermediate lobes of the bovine pituitary contained a mem- 
brane-bound aminopeptidase activity which cleaved arginine from /I-LPHse5 (Arg-Tyr-Gly-Gly-Phe-Met) 
and Arg-MCA. Neither methionine enkephalin (Tyr-Gly-Gly-Phe-Met) nor Substance P, which has an N- 
terminal arginine followed by a proline, could serve as substrates for this aminopeptidase activity; nor could 
cathepsin B-like or chymotrypsin-like enzyme activities be detected in the vesicle preparations. Maximal 
enzyme activity was at pH 6.0, and the activity was inhibited by EDTA, stimulated by Coz+ and Znz+, but 
was unaffected by leupeptin, pepstatin A, phenylmethylsulfonyl fluoride and p-chloromercuribenzenesul- 
fonate, suggesting that the enzyme is a metalloaminopeptidase. The presence of this aminopeptidase activity 
in secretory vesicles uggests that it may be involved in peptide prohormone processing. 
Aminopeptidase Prohormone processing (converting) enzyme 
Intermediate lobe 
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1. INTRODUCTION 
The conversion of peptide prohormones to bio- 
logically active peptides requires a sequence of 
enzymatic post-translational processing steps 
which appear to occur within secretory vesicles 
[ 1,2]. The first cleavages often occur at sites in the 
prohormone which contain pairs of basic amino 
acids (e.g., Lys-Arg) and prohormone converting 
enzyme activities which cleave at these sites have 
been found in intermediate [3] and neural [3,4] 
lobe secretory vesicles in the pituitary. The tradi- 
tional view has been that following this cleavage, 
a carboxypeptidase-B-like enzyme was necessary to 
remove the carboxyl-terminal basic amino acids 
from the resultant peptides [5], and such enzymes 
have been reported in secretory vesicles from the 
pituitary neural and intermediate lobes [6,7]. 
Recent studies in our laboratory suggest hat the 
initial cleavage at Lys-Arg sites in pro-opiomelano- 
cortin and pro-oxytocin occurs principally between 
the two basic amino acids (in preparation), there- 
fore also requiring an intravesicular aminopepti- 
dase to remove the arginine from the amino ter- 
minus of an excised peptide. Here, we report the 
preliminary characterization of such an aminopep- 
tidase activity in secretory vesicles isolated from 
the intermediate and neural lobes of the bovine 
pituitary. 
2. MATERIALS AND METHODS 
* To whom correspondence should be addressed 
Previously described methods were used to pre- 
pare pure secretory vesicles from the neural lobes 
(i.e., neurosecretory vesicles, NSVs [8]) and the in- 
termediate lobes (ILSVs [9]) of bovine pituitaries. 
To prepare secretory vesicle membrane (NSV-M or 
ILSV-M) and soluble (NSV-S or ILSV-S) fractions, 
isolated vesicles were diluted lo-fold with ice-cold 
distilled water, lysed by 3 cycles of freeze-thawing, 
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and centrifuged for 1 h at 100000 x gmax on a 
Beckman air-driven ultracentrifuge, Protein con- 
centrations were measured as in [lo] or by the 
fluorescamine method ill]. 
The aminopeptidase activities in the above frac- 
tions were measured by high-pressure liquid chro- 
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Fig. 1. Aminopeptidase activity in secretory granules 
(vesicles) purified from neural lobe (NSV, left) and inter- 
mediate lobe (ILSV, right) of the bovine pituitary. 
Soluble or membrane fractions from the isolated vesicles 
(22pg protein) were incubated with buffers containingfl- 
LPH~o-6s (0.63 mM) for 1 h at 37°C. The incubates were 
then acidified to pH 1 with HCl, centrifuged for 30 min 
at 100000 x gm,, and the supernatants analysed by 
HPLC (see section 2). HPLC absorbance patterns, 
recorded at 280nm, are shown together with the reten- 
tion times of the ,&LPHc,~-65 substrate (arrow) and 
methionine enkephalin product (arrow). Left: top, con- 
trol incubation with neurosecretory vesicle membranes 
at pH 1 (NSV-M, pH 1); middle, NSV-M incubation at 
pH6; bottom, NSV-S (soluble) fraction incubated at 
pH 6. Right: incubations with membranes (ILSV-M) or 
soluble (ILSV-S) fractions from intermediate lobe 
vesicles. Note substantial generations of met enkephalin 
from&LPH6+65 at pH 6 with NSV-M and ILSV-M, but 
significantly lower activity at this pH using the soluble 
fractions. 
matography (HPLC) and fluorometric assay, The 
HPLC procedure is illustrated in fig. 1. Between 20 
and 25pg protein from a given vesicle fraction was 
incubated in 60~1 incubation buffer (see below) 
containing 0.63 mM @-LPHsO+s (Arg-Tyr-Gly- 
Gly-Phe-Met) as the substrate. The&LP&,+65 was 
obtained from Peninsula Laboratories (Belmont, 
CA) as was the HPLC standard for the product, 
met-enkephalin (Tyr-Gly-Gly-Phe-Met). Incuba- 
tions were for 1 h at 37”C, which was found to be 
in the linear range of the assay (not shown). Fol- 
lowing the incubation, the incubates were acidified 
to pH 1 with HCI, and centrifuged for 30 min at 
100000 x g,,, in a Beckman airfuge. The superna- 
tants were injected onto a Hi-pore, RP-304 Reverse- 
Phase Column (Biorad Laboratories, Richmond, 
CA) connected to a Beckman model 332 HPLC 
system. The eluant was isocratic 0.1070 trifluor- 
acetic acid (TFA), 30% methanol, and absorbance 
was monitored at 280 nm. The retention times for 
the ,&LPH60_65 substrate and the met-enkephalin 
product, in this system, were 8.4 and 9,4min, 
respectively (see arrows in fig.1). In most of the 
incubations, which were conducted at pH 6, either 
of two buffers were used, 0.1 M 2-[N-morpho- 
lino]eth~esulfonic acid (Mes) or 0. I M sodium 
phosphate. No significant differences in activity 
were found between these buffers. Other buffers 
used were: pH 2-4.5, 0.1 M sodium citrate; pH 
4.5-5.5, 0.1 M sodium acetate; pH 5.5-7.5, 
0.1 M sodium phosphate; pH 7.5-9.0, Tris-HCl. 
Quantitative measurements of the peptides (in Fgs) 
were made from HPLC peak heights (at 280 nm 
absorbance) compared to standard curves of peak 
heights vs peptide quantity for both P-LPH60-65 
and met-enkephalin. Kinetic constants for both the 
HPLC and fluorogenic assays (below) were caicu- 
lated from Lineweaver-Burk plots by conven- 
tional procedures. Incubations of vesicle extracts 
with substance P and met-enkephalin as potential 
substrates were also as described above, except 
that the substance P HPLC assay used an isocratic 
0.1% TFA, 45% methanol eluant. The retention 
times for substance P and its potential aminopepti- 
dase product desArg’ substance P were 7.5 and 
8.8 min, respectively. The substance P HPLC 
assay was monitored at 212nm absorbance. 
Incubations and buffers-for the fluorometric 
assays were identical to those described above. The 
fluorogenic substrates used in this study, Arg- 
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Fig.2. pH dependency of aminopeptidase activity in 
NSV-M and ILSV-M using the fl-LPH60-65 substrate 
(for NSV-M) and the fluorogenic Arg-MCA substrate 
(for NSV-M and ILSV-M). The maximum activity in 
both preparations was at pH6.0. 
MCA and Leu-MCA (aminopeptidase substrates), 
Lys-Ala-MCA (diaminopeptidase II substrate), 
Succ-Leu-Leu-Val-Tyr-MCA (chymotrypsin sub- 
strate), and Z-Arg-Arg-MCA (cathepsin B sub- 
strate), and the AMC standard were obtained from 
Peninsula Laboratories. The MCA-substrates and 
standard AMC were dissolved in dimethyl sul- 
foxide (DMSO) as stock solutions, and were em- 
ployed using conventional procedures [12]. The 
fluorescence of the samples was measured using an 
excitation wavelength of 383 nm and an emission 
wavelength of 455nm, on an Aminco SPF125 
spectrofluorometer (American Instrument Co., 
Silver Spring, MD). The protease inhibitors, 
leupeptin, and pepstatin A were obtained from 
Peninsula Laboratories, and the PCMS (p-chloro- 
mercuribenzenesulfonate), PMSF (phenylmethyl- 
sulfonylfluoride) and EDTA were obtained from 
Sigma (St. Louis, MO). 
3. RESULTS 
Fig. 1 illustrates the HPLC assays of ,&LPH,jo_as 
conversion to met-enkephalin by the aminopepti- 
dase activity in NSVs and ILSVs. Over 95% of the 
aminopeptidase activity at pH 6 was found asso- 
ciated with the membrane fractions, i.e., the NSV- 
M (middle left trace) and ILSV-M (middle right 
trace) as opposed to the respective soluble frac- 
tions (NSV-S and ILSV-S). The pH range of the 
aminopeptidase activity is shown in fig.2. Two 
assays of the aminopeptidase activity in the NSV- 
M fraction, the conversion of &LPH60_6s to met- 
enkephalin (HPLC assay) and a fluorometric assay 
using the aminopeptidase substrate Arg-MCA, 
Table 1 
Kinetic constants of aminopeptidase activity in NSV-Ma 
Substrate K, 
(x 1O-6 M) 
V max 
(amol/,ug protein per h) 
A. Peptide substrates 
P-LPHao-65 195.0 0.005 
Methionine enkephalin b 
Substance P b 
B. MCA substrates 
Arg-MCA 13.8 0.003 
Leu-MCA 27.0 0.008 
Lys-Ala-MCA 220.0 0.008 
Z-Arg-Arg-MCA b 
Succ-Leu-Leu-Val-Tyr-MCA b 
a The incubations in these studies were done at 37°C for 1 h, pH 6.0. The peptide substrates 
were assayed by HPLC and the fluorogenic (MCA) substrates by spectrofluorometry (see 
section 2). Concentration of substrates used in these kinetic studies ranged from 1OpM to 
0.5 mM 
b No activity detected 
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show a broad pH curve with a maximum at pH 6.0, 
and with half-maximum activities ranging from 
pH 5.5-7.5. Essentially identical data were ob- 
tained with ILSV-M fractions using the Arg-MCA 
assay (fig.2). 
Kinetic constants for the aminopeptidase activity 
in the NSV-M preparations were determined from 
conventional Lineweaver-Burk plots (not shown). 
Table 1 illustrates these values for the aminopepti- 
dase substrates, &LPHee-65, and Arg-MCA shown 
in fig.2, as well as for a number of other sub- 
strates. All incubations were performed at pH 6 
and 37°C. Significant enzyme activities were de- 
tected using the ,&LPHb0_65, Arg-MCA, and Leu- 
MCA aminopeptidase substrates, and the diamino- 
peptidase substrate, Lys-Ala-MCA. Although the 
V,,, values were comparable between these sub- 
strates, ranging from 0.003-O.O08,~mol/~g protein 
per h, the K,,, values varied considerably from 
13.8uM for Arg-MCA to 220pM for Lys-Ala- 
MCA. It is notable that neither methionine-en- 
kephalin with an amino terminus tyrosine nor sub- 
stance P (which has an Arg at its N-terminus, 
followed by a proline) could serve as substrates for 
the vesicle enzyme(s) (table 1A). In the latter ex- 
periments, incubations were carried out for as long 
as 5-12 h at 37°C with no evidence of degradation 
of the met-enkephalin or substance P substrates. 
The lack of activity on the Z-Arg-Arg-MCA sub- 
strate (table 1B) suggests that this vesicle mem- 
brane activity is not due to an Arg-specific endo- 
peptidase (e.g., cathepsin B). In addition, no 
chymotrypsin-like activity could be detected in the 
NSV-M fraction using the Succ-Leu-Leu-Val-Tyr- 
MCA substrate (table 1B). 
Tests of various inhibitors on the NSV-M amino- 
peptidase activity indicate that it is a metallopro- 
tease (table 2). EDTA (0.5 mM) inhibited its 
activity, and Co’+ and Zn*+ strongly stimulated its 
activity. Cu*+ strongly inhibited the activity, 
Table 2 
Effects on ions and inhibitors on NW-M aminopeptidase activitya 
Inhibitor (mM) Control activity (vo) 
,&LPH60-65 substrate Arg-MCA substrate 
A. Ions 
co+ EDTA co:,’ 
cu*+ (015) 
1;; 1:; 
16 7 
Zn2+ (0.5) 197 150 
Mg2+ (0.5) 90 106 
Ca2+ (0.5) 85 88 
B. Recovery from partial EDTA inhibition 
EDTA (0.1) 63 60 
EDTA (0.1) + Co’+ (0.5) 106 103 
EDTA (0.1) + Cu2+ (0.5) 42 57 
EDTA (0.1) + Zn*+ (0.5) 118 98 
EDTA (0.1) + Mg’+ (0.5) 54 55 
EDTA (0.1) + Ca*+ (0.5) 55 66 
C. Protease inhibitors 
Leupeptin (0.5) 
Pepstatin A (0.5) 
PMSF (1) 
PCMS (1) 
96 100 
88 101 
109 99 
110 102 
a Assays were done using P-LPH@-65 (0.6 mM) and Arg-MCA (0.5 mM) substrates as 
described in section 2 
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whereas Ca*+ and Mg*+ appeared to have no 
significant effect (table 2A for both fl-LPHao-65 
and Arg-MCA substrates). Partial inhibition of the 
NSV-M enzyme activity (60-63%) by 0.1 mM 
EDTA is reversed only by Co*+ and Zn*+ (table 
2B). Leupeptin, pepstatin A, PMSF, and PCMS at 
0.5-l .O mM concentrations were without effect on 
the NSV-M aminopeptidase activity, indicating 
that it is not a cysteinyl, aspartyl, or serine pro- 
tease (table 2C). 
4. DISCUSSION 
We report here the presence of an aminopepti- 
dase activity in secretory vesicles, isolated from the 
neural and intermediate lobes of the bovine 
pituitary, which specifically cleaves Arg from the 
NH2 terminus offi-LPH6+65. This enzyme activity 
is membrane bound, maximally active at acid pH 
values (i.e., pH 6.0), and appears to be a metallo- 
protease since EDTA inhibits its activity, whereas 
serine (i.e., PMSF), cysteinyl (PMCS), and aspar- 
tyl (pepstatin A) protease inhibitors do not affect 
its activity (table 2). The acidic pH optimum (fig.2) 
is consistent with its putative role as a peptide pro- 
cessing enzyme in secretory vesicles which have an 
internal pH of 5.1-5.5 [1,2]. 
It is of significance that of the peptide substrates 
tested (table lA), only the amino-terminal argi- 
nine in fl-LPH60_65 could serve as a substrate 
(fig.1). The product of this reaction, methionine 
enkephalin, could not be degraded by this enzyme 
activity. Therefore, this enzyme activity differs 
from the membrane-associated nkephalin-degrad- 
ing aminopeptidases which have been reported in a 
variety of other tissue preparations [ 13- 161. This 
intravesicular aminopeptidase resembles amino- 
peptidase-B in that it appears to cleave amino- 
terminal arginine [17-191, but cannot function if 
the second amino acid in the peptide is a proline 
[17], as is the case in substance P (table 1A). How- 
ever, since aminopeptidase-B is a neutral enzyme 
(pH optimum 7.2) and a serine protease [21-231, 
the intravesicular aminopeptidase activity we have 
described clearly is different. Nor does it corres- 
pond in its characteristics to leucine aminopepti- 
dase, aminopeptidase-M or dipeptidyl-aminopep- 
tidases I-IV [17,20]. Table 2 and fig.2 indicate 
that the enzyme activities measured by the ,&- 
LPH~o-6s and Arg-MCA assays have similar 
characteristics, and suggest that both assays are 
measuring the same enzyme. Efforts are now 
under way in our laboratory to purify these amino- 
peptidase(s) and fully characterize them. 
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